Medikamentöse therapie der rheumatoiden arthritis

Translated title of the contribution: Current drug therapy in rheumatoid arthritis

T. A. Bongartz, O. Distler, U. Müller-Ladner

Research output: Contribution to journalReview article


The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.

Translated title of the contributionCurrent drug therapy in rheumatoid arthritis
Original languageGerman
Pages (from-to)141-151
Number of pages11
JournalInternistische Praxis
Issue number1
StatePublished - Mar 1 2006


  • Biologics
  • Coxibs
  • Rheumatoid arthritis
  • Steroids

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Current drug therapy in rheumatoid arthritis'. Together they form a unique fingerprint.

  • Cite this

    Bongartz, T. A., Distler, O., & Müller-Ladner, U. (2006). Medikamentöse therapie der rheumatoiden arthritis. Internistische Praxis, 46(1), 141-151.